We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Chart Review of Outcome of Treatment for S. Aureus Bacteremia

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00304902
First Posted: March 20, 2006
Last Update Posted: September 10, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Baylor College of Medicine
Information provided by:
VA Medical Center, Houston
  Purpose
The purpose of this study is to review medical records at MEDVAMC in order to relate the outcome of bacteremic MRSA infection to the antibiotics selected for treatment.

Condition
Staphylococcus Aureus

Study Type: Observational
Study Design: Observational Model: Ecologic or Community
Time Perspective: Retrospective
Official Title: Retrospective Chart Review of the Outcome of Treatment for Staphylococcus Aureus Bacteremia

Resource links provided by NLM:


Further study details as provided by VA Medical Center, Houston:

Enrollment: 120
Study Start Date: February 2006
Study Completion Date: August 2010
Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)
  Show Detailed Description

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 64 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All patients with Staphylococcus aureus in a blood culture.
Criteria

Inclusion Criteria:

  • Patients with Staphylococcus aureus in a blood culture between January 1, 2004 and December 31, 2005.

Exclusion Criteria:

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00304902


Locations
United States, Texas
Michael E. DeBakey Veterans Affairs Medical Center
Houston, Texas, United States, 77030
Sponsors and Collaborators
VA Medical Center, Houston
Baylor College of Medicine
Investigators
Principal Investigator: Daniel M Musher, M.D. Baylor College of Medicine, Houston VA Medical Center
  More Information

Responsible Party: Nancy Logan, MA, VAMC
ClinicalTrials.gov Identifier: NCT00304902     History of Changes
Other Study ID Numbers: H-18867
First Submitted: March 16, 2006
First Posted: March 20, 2006
Last Update Posted: September 10, 2010
Last Verified: September 2010

Keywords provided by VA Medical Center, Houston:
MRSA
Methicillin Resistant Staphylococcus aureus
Staphylococcus aureus Bacteremia

Additional relevant MeSH terms:
Bacteremia
Bacterial Infections
Sepsis
Infection
Systemic Inflammatory Response Syndrome
Inflammation
Pathologic Processes